ARMP (Armata Pharmaceuticals, Inc.) Company Cash Funds

Corporate emblem and logo of Armata Pharmaceuticals (ARMP)

Armata Pharmaceuticals (ARMP) adheres to basic environmental standards when disposing of laboratory reagents. The company is developing breakthrough methods to combat superbugs by investing in overcoming antibiotic resistance. The cash balance on the balance sheet demonstrates financial stability, where 0.02 represents the current level of the metric. Developments are protected by strain patents, although strict biocontrol and formula complexity limit market access.

ARMP - Armata Company Cash Volume over the range 07/04/2022 - 11/21/2026

Analytical breakdowns for Armata Pharmaceuticals

- stock value and consensus price forecast:
- cash position and cash flow details:
Fundamental valuation:ARMP Armata Pharma
Brand item of Armata Pharmaceuticals Inc

Amid uncertainty, investors prioritize capital preservation through liquidity analysis. This metric aggregates balances across all settlement accounts, determining the business's degree of autonomy from external borrowings. By analyzing current cash holdings, one can identify an excessive accumulation of non-working assets. For Armata Pharmaceuticals (ARMP), this reserve is critical, as the absence of commercial revenue from bacteriophage development makes cash the sole resource until the completion of clinical stages.

Competitor analysis for Armata Pharmaceuticals